Directed differentiation of human iPSCs into mesenchymal lineages by optogenetic control of TGF-β signaling

Cell Rep. 2023 May 30;42(5):112509. doi: 10.1016/j.celrep.2023.112509. Epub 2023 May 12.

Abstract

In tissue development and homeostasis, transforming growth factor (TGF)-β signaling is finely coordinated by latent forms and matrix sequestration. Optogenetics can offer precise and dynamic control of cell signaling. We report the development of an optogenetic human induced pluripotent stem cell system for TGF-β signaling and demonstrate its utility in directing differentiation into the smooth muscle, tenogenic, and chondrogenic lineages. Light-activated TGF-β signaling resulted in expression of differentiation markers at levels close to those in soluble factor-treated cultures, with minimal phototoxicity. In a cartilage-bone model, light-patterned TGF-β gradients allowed the establishment of hyaline-like layer of cartilage tissue at the articular surface while attenuating with depth to enable hypertrophic induction at the osteochondral interface. By selectively activating TGF-β signaling in co-cultures of light-responsive and non-responsive cells, undifferentiated and differentiated cells were simultaneously maintained in a single culture with shared medium. This platform can enable patient-specific and spatiotemporally precise studies of cellular decision making.

Keywords: CP: Developmental biology; TGF-β signaling; differentiation; human induced pluripotent stem cells; mesenchymal stem cells; optogenetics.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, N.I.H., Extramural

MeSH terms

  • Cell Differentiation
  • Cells, Cultured
  • Chondrocytes
  • Chondrogenesis
  • Humans
  • Induced Pluripotent Stem Cells* / metabolism
  • Mesenchymal Stem Cells* / metabolism
  • Optogenetics
  • Signal Transduction
  • Transforming Growth Factor beta / metabolism

Substances

  • Transforming Growth Factor beta